A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma

Epigenetic alterations by histone/protein deacetylases (HDACs) are one of the many mechanisms that cancer cells use to alter gene expression and promote growth. HDAC inhibitors have proven to be effective in the treatment of specific malignancies, particularly in combination with other anticancer ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Nageatte, Buchbinder, Elizabeth I., Granter, Scott R., Rodig, Scott J., Giobbie‐Hurder, Anita, Becerra, Carla, Tsiaras, Argyro, Gjini, Evisa, Fisher, David E., Hodi, F. Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119958/
https://www.ncbi.nlm.nih.gov/pubmed/27748045
http://dx.doi.org/10.1002/cam4.862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119958/
https://www.ncbi.nlm.nih.gov/pubmed/27748045
http://dx.doi.org/10.1002/cam4.862

Ejemplares similares